A randomized controlled trial to evaluate genotyping and therapeutic drug monitoring vs. only therapeutic drug monitoring as a strategy for risk minimization in epileptic patients on carbamazepine therapy
Objective: Carbamazepine (CBZ) is a widely prescribed antiepileptic drug for the treatment of focal seizures. CBZ gets metabolized by cytochrome enzymes mainly CYP3A5. It is difficult to predict clinically whether a patient is likely to suffer from CBZ toxicity. Hence, we planned to evaluate the use...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Atatürk University
2025-04-01
|
| Series: | Recent Trends in Pharmacology |
| Subjects: | |
| Online Access: | https://dergipark.org.tr/en/download/article-file/4496181 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|